Closing Bell: Medicenna Therapeutics Corp up on Wednesday (MDNA)

Today during trading, Medicenna Therapeutics Corp shares closed at $2.13 after opening the day at $2.04. prices ranged from a low of $2.00 to a high of $2.16.

Shares boosted 4.41 percent from the previous day's close of $2.04.

During the day across North America, the TSX Composite closed 1.25% at 23110.81, the S&P 500 closed -0.50% at 5436.44, the Dow Jones Industrial Average closed 0.50% at 40743.33 and the Nasdaq Composite closed -1.28% at 17147.42.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 79,271 shares was traded during the session, with total trades of 129. On average, Medicenna Therapeutics Corp has traded 88,333 shares in the last five days and 123,638 year-to-date.

The TSX market on the whole today saw 3,418 price advancers against 1,773 declines and 138 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, in the last 52 weeks, Medicenna Therapeutics Corp's shares have risen 273.68%, while in 2024, they have risen 407.14%.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $152.55 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Based on 2.00 analysts, Medicenna Therapeutics Corp gets an average recommendation of "Strong Buy" according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..